Evidence map›Paper›PMID 38298536›Full record

ArticleFrontiers in microbiology2023

Inactivation kinetics of selected pathogenic and non-pathogenic bacteria by aqueous ozone to validate minimum usage in purified water.

Yuqian Lou, David R Kasler, Zach L Hawkins, Zhen Li, Dan Sannito, Ronald D Fritz, Ahmed E Yousef

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuqian LouPepsiCo R&D, Valhalla, NY, United States.
David R KaslerDepartment of Food Science and Technology, The Ohio State University, Columbus, OH, United States.
Zach L HawkinsDepartment of Food Science and Technology, The Ohio State University, Columbus, OH, United States.
Zhen LiPepsiCo R&D, Valhalla, NY, United States.
Dan SannitoPepsiCo R&D, Valhalla, NY, United States.
Ronald D FritzInSite Technologies, Inc., Burnsville, NC, United States.
Ahmed E YousefDepartment of Food Science and Technology, The Ohio State University, Columbus, OH, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ozone is often used as an antimicrobial agent at the final step in purified water processing. When used in purified bottled water manufacturing, residual ozone should not exceed 0.4 mg/L, per US-FDA regulations. These regulations require the control of

Indexed as

Ct valuedata modelingEnterococcus faeciumheteroscedasticityozonepathogenic bacteriapurified waterwater pathogen surrogate

Identifiers

PMID38298536
PMCPMC10829095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.